𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

✍ Scribed by Saag, Kenneth G.; Emkey, Ronald; Schnitzer, Thomas J.; Brown, Jacques P.; Hawkins, Federico; Goemaere, Stefan; Thamsborg, Gorm; Liberman, Uri A.; Delmas, Pierre D.; Malice, Marie-Pierre; Czachur, Michelle; Daifotis, Anastasia G.; Lane, Nancy; Correa-Rotter, Ricardo; Yanover, Melissa; Westhovens, Rene; Epstein, Sol; Adachi, Jonathan D.; Poubelle, Patrice; Melo-Gomes, Jose; Rodriguez-Portales, Jose A.

Book ID
120365692
Publisher
Massachusetts Medical Society
Year
1998
Tongue
English
Weight
128 KB
Volume
339
Category
Article
ISSN
0096-6762

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prevention of glucocorticoid-induced ost
Prevention of glucocorticoid-induced osteoporosis
✍ Dr. Ian R. Reid; Beth A. Schooler; Alistair W. Stewart πŸ“‚ Article πŸ“… 2009 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 421 KB
Uncertainties in the prevention and trea
Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis
✍ Karen E Hansen; H Alexander Wilson; Carol Zapalowski; Howard A Fink; Salvatore M πŸ“‚ Article πŸ“… 2011 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 96 KB

## Abstract Much knowledge has accrued since the 2001 American College of Rheumatology (ACR) guidelines were published to assist clinicians in the prevention and treatment of glucocorticoid‐induced osteoporosis (GIO). Therefore, the ACR undertook a comprehensive effort to review the literature and